1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Neurological Biomarkers Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Neurological Biomarkers Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1
- 5.1.2 Rising incidences of neurological diseases
- 5.1.3 Rapid Developments in healthcare
5.2 Market Opportunities
- 5.2.1
- 5.2.2 Development of novel biomarkers
- 5.2.3 Integration of drug development and biomarkers
- 5.2.4 Focus on early detection and prevention
5.3 Future Trends
- 5.3.1
- 5.3.2 Advancement in biomarker discovery
- 5.3.3 increased focus on personalized medicines
5.4 Impact of Drivers and Restraints
6. North America Neurological Biomarkers Market Regional Analysis
6.1 North America Neurological Biomarkers Market Overview
6.2 North America Neurological Biomarkers Market Revenue 2017-2027 (US$ Million)
6.3 North America Neurological Biomarkers Market Forecast Analysis
7. North America Neurological Biomarkers Market Analysis – by Product
7.1 Proteomics Biomarker
- 7.1.1 Overview
- 7.1.2 Proteomics Biomarker: North America Neurological Biomarkers Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Genomics Biomarker
- 7.2.1 Overview
- 7.2.2 Genomics Biomarker: North America Neurological Biomarkers Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Metabolomics Biomarker
- 7.3.1 Overview
- 7.3.2 Metabolomics Biomarker: North America Neurological Biomarkers Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Imaging Biomarker
- 7.4.1 Overview
- 7.4.2 Imaging Biomarker: North America Neurological Biomarkers Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Neurological Biomarkers Market Analysis – by Application
8.1 Alzheimer's Disease
- 8.1.1 Overview
- 8.1.2 Alzheimer's Disease: North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Parkinson's Disease
- 8.2.1 Overview
- 8.2.2 Parkinson's Disease: North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Schizophrenia
- 8.3.1 Overview
- 8.3.2 Schizophrenia: North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Huntington's Disease
- 8.4.1 Overview
- 8.4.2 Huntington's Disease: North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Spinal Muscular Atrophy
- 8.5.1 Overview
- 8.5.2 Spinal Muscular Atrophy: North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Neurological Biomarkers Market Analysis – by End User
9.1 Pharmaceutical and Biotechnology Companies
- 9.1.1 Overview
- 9.1.2 Spinal Muscular Atrophy: North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Clinical Diagnostics
- 9.2.1 Overview
- 9.2.2 Spinal Muscular Atrophy: North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Research Organizations
- 9.3.1 Overview
- 9.3.2 Spinal Muscular Atrophy: North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Neurological Biomarkers Market – North America Analysis
10.1 North America
- 10.1.1 North America Neurological Biomarkers Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.1.1.1 North America Neurological Biomarkers Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America Neurological Biomarkers Market Breakdown, by Product
- 10.1.1.1.2 US: North America Neurological Biomarkers Market Breakdown, by Application
- 10.1.1.1.3 US: North America Neurological Biomarkers Market Breakdown, by End User
- 10.1.1.2 Canada:
North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America Neurological Biomarkers Market Breakdown, by Product
- 10.1.1.2.2 Canada: North America Neurological Biomarkers Market Breakdown, by Application
- 10.1.1.2.3 Canada: North America Neurological Biomarkers Market Breakdown, by End User
- 10.1.1.3 Mexico :
North America Neurological Biomarkers Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America Neurological Biomarkers Market Breakdown, by Product
- 10.1.1.3.2 Mexico : North America Neurological Biomarkers Market Breakdown, by Application
- 10.1.1.3.3 Mexico : North America Neurological Biomarkers Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Neurological Biomarkers Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Thermo Fisher Scientific, Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bio-Rad Laboratories Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Banyan Biomarkers
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Abbott
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Quest Diagnostics Incorporated
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Perkin Elmer, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Neurological Biomarkers Market
